Healthcare

Alterity Therapeutics (ASX:ATH) is approaching an important stage in the development of ATH434, its lead drug candidate for Multiple System Atrophy, or MSA.

Lumos Diagnostics Holdings (ASX:LDX) is developing a commercial platform around point-of-care diagnostics, with FebriDx sitting at the centre of theInvestmentcase.

Mach7 Technologies (ASX:M7T) operates in a specialised part of healthcare technology, providing enterprise imaging, vendor-neutral archiving and diagnostic viewing software to hospitals and health systems.

Sigma Healthcare (ASX:SIG) has been transformed from a traditional pharmaceutical wholesaler into a much larger integrated retail and wholesale healthcare group following its combination with Chemist Warehouse.

Beamtree Holdings (ASX:BMT) sits in a corner of the market that rarely generates headlines but addresses a genuine problem: helping hospitals and health systems use their own clinical data to improve patient outcomes and control costs. The company supplies coding, decision-support and benchmarking software …

Paragon Care (ASX:PGC) has transformed from a mid-sized medical products distributor into one of the larger healthcare businesses on the ASX, and its FY26 results on 26 August 2026 showed both the scale of that ambition and the growing pains that come with it. …

SomnoMed (ASX:SOM) occupies a distinctive corner of the medical-device market: it makes custom oral appliances used to treat obstructive sleep apnoea, offering an alternative to the bulkier CPAP machines that many patients struggle to tolerate. After years of restructuring and reinvestment, the company's FY26 …